Advertisement

Serum microRNAs as diagnostic markers of endometriosis: a comprehensive array-based analysis

      Objective

      To investigate serum microRNAs (miRNAs) in women with endometriosis.

      Design

      Case-control study.

      Setting

      University hospital.

      Patient(s)

      Women with (n = 24) and without (n = 24) endometriosis.

      Intervention(s)

      Serum samples were obtained from surgically diagnosed subjects.

      Main Outcome Measure(s)

      miRNA from women with without endometriosis were used for microarray profiling and confirmed by means of quantitative real-time polymerase chain reaction (qRT-PCR). Receiver operating characteristic (ROC) analysis was performed on differentially expressed miRNAs.

      Result(s)

      miR-3613-5p, miR-6755-3p were down-regulated and miR-125b-5p, miR-150–5p, miR-342-3p, miR-143-3p, miR-145-5p, miR-500a-3p, miR-451a, miR-18a-5p were up-regulated more than 10-fold in the microarray. These results were confirmed with the use of qRT-PCR. Among the differentially expressed miRNAs, miR-125b-5p expression levels had the highest area under the ROC curve (AUC). The maximum AUC score of 1.000 was achieved when combining miR-125b-5p, miR-451a, and miR-3613-5p with the use of a logistic regression model.

      Conclusion(s)

      We identified several miRNAs in serum that distinguished subjects with endometriosis from those without. miR-125b-5p had the greatest potential as a single diagnostic biomarker. A combination of that miRNA with miR-451a and miR-3613-5p further improved diagnostic performance.

      Key Words

      To read this article in full you will need to make a payment

      Subscribe:

      Subscribe to Fertility and Sterility
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Bartel D.P.
        MicroRNAs: target recognition and regulatory functions.
        Cell. 2009; 136: 215-233
        • Hassan M.Q.
        • Tye C.E.
        • Stein G.S.
        • Lian J.B.
        Noncoding RNAs: Epigenetic regulators of bone development and homeostasis.
        Bone. 2015; 81: 746-756
        • Corcoran C.
        • Friel A.M.
        • Duffy M.J.
        • Crown J.
        • O’Driscoll L.
        Intracellular and extracellular microRNAs in breast cancer.
        Clin Chem. 2011; 57: 18-32
        • Sayed A.S.
        • Xia K.
        • Li F.
        • Deg X.
        • Salma U.
        • Li T.
        • et al.
        Diagnosis, prognosis and therapeutic role of circulating miRNAs in cardiovascular diseases.
        Heart Lung Cir. 2014; 23: 503-510
        • Coskun M.
        • Bjerrum J.T.
        • Seidelin J.B.
        • Nielsen O.H.
        MicroRNAs in inflammatory bowel disease-pathogenesis, diagnostics and therapeutics.
        World J Gastroenterol. 2012; 18: 4629-4634
        • Dorval V.
        • Nelson P.T.
        • Hebert S.S.
        Circulating microRNAs in Alzheimer’s disease: the search for novel biomarkers.
        Front Mol Neurosci. 2013; 6: 24
        • Jin X.F.
        • Wu N.
        • Wang L.
        • Li J.
        Circulating microRNAs: a novel class of potential biomarkers for diagnosing and prognosing central nervous system diseases.
        Cell Mol Neurobiol. 2013; 5: 601-613
        • Liu H.S.
        • Xiao H.S.
        MicroRNAs as potential biomarkers for gastric cancer.
        World J Gastroenterol. 2014; 20: 12007-12017
        • Ulivi P.
        • Zoli W.
        miRNAs as noninvasive biomarkers for lung cancer diagnosis.
        Molecules. 2014; 19: 8220-8237
        • Zhu J.
        • Zheng Z.
        • Wang J.
        • Sun J.
        • Wang P.
        • Cheng X.
        • et al.
        Different miRNA expression profiles between human breast cancer tumors and serum.
        Front Genet. 2014; 5: 149
        • Bandiera S.
        • Pfeffer S.
        • Baumert T.F.
        • Zeisel M.B.
        miR-122-a key factor andtherapeutic target in liver disease.
        J Hepatol. 2015; 62: 448-457
        • Chen X.
        • Ba Y.
        • Ma L.
        • Cai X.
        • Yin Y.
        • Wang K.
        • et al.
        Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases.
        Cell Res. 2008; 18: 997-1006
        • Schwarzenbach H.
        • Nishida N.
        • Calin G.A.
        • Pantel K.
        Clinical relevance of circulating cell- free microRNAs in cancer.
        Nat Rev Clin Oncol. 2014; 11: 145-156
        • Gallo A.
        • Tandon M.
        • Alevizos I.
        • Illei G.G.
        The majority of microRNAs detectable in serum and saliva is concentrated in exosomes.
        PLoS One. 2012; 7: e30679
        • Turchinovich A.
        • Weiz L.
        • Langheinz A.
        • Burwinkel B.
        Characterization of extracellular circulating microRNA.
        Nucleic Acids Res. 2011; 39: 7223-7233
        • Arroyo J.D.
        • Chevillet J.R.
        • Kroh E.M.
        • Ruf I.K.
        • Pritchard C.C.
        • Gibson D.F.
        • et al.
        Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma.
        Proc Natl Acad Sci U S A. 2011; 108: 5003-5008
        • Lai C.Y.
        • Wu Y.T.
        • Yu S.L.
        • Yu Y.H.
        • Lee S.Y.
        • Liu C.M.
        • et al.
        Modulated expression of human peripheral blood microRNAs from infancy to adulthood and its role in aging.
        Aging Cell. 2014; 13: 679-689
        • Redni S.T.
        • Gadd S.
        • Jafari N.
        • Huang C.C.
        A parallel study of mRNA and microRNA profiling of peripheral blood in young adult women.
        Front Genet. 2011; 2: 49
        • Zhao Z.
        • Zhao Q.
        • Warrick J.
        • Lockwood C.M.
        • Woodworth A.
        • Moley K.H.
        • et al.
        Circulating microRNA miR-323-3p as a biomarker of ectopic pregnancy.
        Clin Chem. 2012; 58: 896-905
        • Murri M.
        • Insenser M.
        • Fernandez-Duran E.
        • San-Millan J.L.
        • EscobarMorreale H.F.
        Effects of polycystic ovary syndrome (PCOS), sex hormones, and obesity on circulating miRNA-21, miRNA-27b, miRNA-103, and miRNA-155 expression.
        J Clin Endocrinol Metab. 2013; 98: E1835-E1844
        • Taylor H.S.
        • Osteen K.G.
        • Bruner-Tran K.L.
        • Lockwood C.J.
        • Krikun G.
        • Sokalska A.
        • et al.
        Novel therapies targeting endometriosis.
        Reprod Sci. 2011; 18: 814-823
        • Giudice L.C.
        Clinical practice. Endometriosis.
        N Engl J Med. 2010; 362: 2389-2398
        • Bulun S.E.
        Endometriosis.
        N Engl J Med. 2009; 360: 268-279
        • Eskenazi B.
        • Warner M.L.
        Epidemiology of endometriosis.
        Obstet Gynecol Clin North Am. 1997; 24: 235-258
        • Ozkan S.
        • Murk W.
        • Arici A.
        Endometriosis and infertility: epidemiology and evidence-based treatments.
        Ann N Y Acad Sci. 2008; 1127: 92-100
        • Moradi M.
        • Parker M.
        • Sneddon A.
        • Lopez V.
        • Ellwood D.
        Impact of endometriosis on women’s lives: a qualitative study.
        BMC Womens Health. 2014; 14: 123
        • Dunselman G.A.
        • Vermeulen N.
        • Becker C.
        • Calhaz-Jorge C.
        • d’Hooghe T.
        • de Bie B.
        • et al.
        ESHRE guideline: management of women with endometriosis.
        Hum Reprod. 2014; 29: 400-412
        • Wang H.
        • Zhang P.
        • Chen W.
        • Feng D.
        • Jia Y.
        • Xie L.X.
        Evidence for serum miR-15a and miR-16 levels as biomarkers that distinguish sepsis from systemic inflammatory response syndrome in human subjects.
        Clin Chem Lab Med. 2012; 50: 1423-1428
        • Jia S.Z.
        • Yang Y.
        • Lang J.
        • Sun P.
        • Leng J.
        Plasma miR-17-5p, miR-20a and miR-22 are down-regulated in women with endometriosis.
        Hum Reprod. 2013; 28: 322-330
        • Suryawanshi S.
        • Vlad A.M.
        • Lin H.M.
        • Mantia-Smaldone G.
        • Laskey R.
        • Lee M.
        • et al.
        Plasma microRNAs as novel biomarkers for endometriosis and endometriosis-associated ovarian cancer.
        Clin Cancer Res. 2013; 19: 1213-1224
        • Ohlsson Teague E.M.
        • van der Hoek K.H.
        • Van der Hoek M.B.
        • Perry N.
        • Wagaarachchi Robertson S.A.
        • et al.
        MicroRNA-regulated pathways associated with endometriosis.
        Mol Endocrinol. 2009; 23: 265-275
        • Petracco R.
        • Grechukhina O.
        • Popkhadze S.
        • Massasa E.
        • Zhou Y.
        • Taylor H.S.
        MicroRNA 135 regulates HOXA10 expression in endometriosis.
        J Clin Endocrinol Metab. 2011; 96: E1925-E1933
        • Teague E.M.
        • Print C.G.
        • Hull M.L.
        The role of microRNAs in endometriosis and associated reproductive conditions.
        Hum Reprod Update. 2010; 16: 142-165
        • Resnick K.E.
        • Alder H.
        • Hagan J.P.
        • Richardson D.L.
        • Croce C.M.
        • Cohn D.E.
        The detection of differentially expressed microRNAs from the serum of ovarian cancer patients using a novel real-time PCR platform.
        Gynecol Oncol. 2009; 112: 55-59
        • Wang W.T.
        • Zhao Y.N.
        • Han B.W.
        • Hong S.J.
        • Chen Y.Q.
        Circulating microRNAs identified in a genome-wide serum microRNA expression analysis as noninvasive biomarkers for endometriosis.
        J Clin Endocrinol Metab. 2013; 98: 281-289
        • Cho S.
        • Mutlu L.
        • Grechukhina O.
        • Taylor H.S.
        Circulating microRNAs as potential biomarkers for endometriosis.
        Fertil Steril. 2015; 103: 1252-1260
        • American Society for Reproductive Medicine
        Revised American Society for Reproductive Medicine classification of endometriosis.
        Fertil Steril. 1996; 67: 817-821
        • Kuwabara Y.
        • Ono K.
        • Horie T.
        • Nishi H.
        • Nagao K.
        • Kinoshita M.
        • et al.
        Increased
microRNA-1 and microRNA-133a levels in serum of patients with cardiovascular disease indicate myocardial damage.
        Circ Cardiovasc Genet. 2011; 4: 446-454
        • Nnoaham K.E.
        • Hummelshoj L.
        • Webster P.
        • d’Hooghe T.
        • de Cicco N.F.
        • de Cicco N.C.
        • et al.
        Impact of endometriosis on quality of life and work productivity: a multicenter study across ten countries.
        Fertil Steril. 2011; 96: 366-373
        • Cho S.
        • Choi Y.S.
        • Yim S.Y.
        • Yang H.I.
        • Jeon Y.E.
        • Lee K.E.
        • et al.
        Urinary vitamin D–binding protein is elevated in patients with endometriosis.
        Hum Reprod. 2012; 27: 515-522
        • Reis F.M.
        • Luisi S.
        • Abrao M.S.
        • Rocha A.L.
        • Vigano P.
        • Rezende C.P.
        • et al.
        Diagnostic value of serum activin A and follistatin levels in women with peritoneal, ovarian and deep infiltrating endometriosis.
        Hum Reprod. 2012; 27: 1445-1450
        • May K.E.
        • Conduit-Hulbert S.A.
        • Villar J.
        • Kirtley S.
        • Kennedy S.H.
        • Becker C.M.
        Peripheral biomarkers of endometriosis: a systematic review.
        Hum Reprod Update. 2010; 16: 651-674
        • Naqvi H.
        • Mamillapalli R.
        • Krikun G.
        • Taylor H.S.
        Endometriosis located proximal to or remote from the uterus differentially affects uterine gene expression.
        Reprod Sci. 2016; 23: 186-191
        • Wang X.
        • Zhang Y.
        • Fu Y.
        • Zhang J.
        • Yin L.
        • Pu Y.
        • et al.
        MicroRNA-125b may function as an oncogene in lung cancer cells.
        Mol Med Rep. 2015; 11: 3880-3887
        • Wang H.
        • Tan G.
        • Dong L.
        • Cheng L.
        • Li K.
        • Wang Z.
        • et al.
        Circulating miR-125b as a marker predicting chemoresistance in breast cancer.
        PLoS One. 2012; 7: e34210
        • Matamala N.
        • Vargas M.T.
        • González-Cámpora R.
        • Miñambres R.
        • Arias J.I.
        • Menéndez P.
        • et al.
        Tumor microRNA expression profiling identifies circulating microRNAs for early breast cancer detection.
        Clin Chem. 2015; 61: 1098-1106
        • Giray B.G.
        • Emekdas G.
        • Tezcan S.
        • Ulger M.
        • Serin M.S.
        • Sezgin O.
        • et al.
        Profiles of serum microRNAs; miR-125b-5p and miR-223-3p serve as novel biomarkers for HBV-positive hepatocellular carcinoma.
        Mol Biol Rep. 2014; 41: 4513-4519
        • Chen S.
        • Yang L.
        • Jie Q.
        • Lin Y.S.
        • Meng G.L.
        • Fan J.Z.
        • et al.
        MicroRNA-125b suppresses the proliferation and osteogenic differentiation of human bone marrow–derived mesenchymal stem cells.
        Mol Med Rep. 2014; 9: 1820-1826
        • Liu G.
        • Xu Z.
        • Hao D.
        MicroRNA-451 inhibits neuroblastoma proliferation, invasion and migration by targeting macrophage migration inhibitory factor.
        Mol Med Rep. 2016; 13: 2253-2260
        • Xu H.
        • Mei Q.
        • Shi L.
        • Lu J.
        • Zhao J.
        • Fu Q.
        Tumor-suppressing effects of miR451 in human osteosarcoma.
        Cell Biochem Biophys. 2014; 69: 163-168
        • Graham A.
        • Falcone T.
        • Nothnick W.B.
        The expression of microRNA-451 in human endometriotic lesions is inversely related to that of macrophage migration inhibitory factor (MIF) and regulates MIF expression and modulation of epithelial cell survival.
        Hum Reprod. 2015; 30: 642-652